Enabio Materials
英华辰睿
Enabio Materials (英华辰睿) is a Chinese biomaterials startup founded in August 2022 by CEO Zhen Zhou, a former Asia-Pacific channel general manager at Fortune 500 company Saint-Gobain . The company focuses on high-performance modification and application innovation for biomaterials, with R&D staff comprising over 60% of its team .
Its core technology centers on multi-step continuous reactive compatibilization and other proprietary modification methods that improve crystallinity and melt strength of materials like PLA (polylactic acid), opening downstream applications in fibers, non-woven fabrics, film lamination, and high-speed 3D printing . The company also works on PHA/PLA blend modifications in partnership with Bluepha (蓝晶微生物), a leading PHA feedstock developer .
In December 2023, Enabio raised tens of millions of RMB in angel funding led by Linear Capital, with Bluepha as a co-investor . Zhou cited Linear's post-investment support—resource matching, talent recruitment, legal assistance, and cross-domain networking—as key factors in the partnership .
AI-generated — may contain errors, please verify.
Coverage
Where Are the Opportunities for China's AI4S Industry in Trump's "Genesis Project"? | Linear Voice
Standing at the historical inflection point of a new Age of Scientific Discovery.
Linear Capital's 2025 Investor Conference Successfully Held in Beijing | Linear News
To be or not to be, in the AI-dominated future.
Taking Gems From Fire — Linear Capital's 2024 Year in Review
2024 is coming to a close. I'd like to borrow the theme from our annual meeting in October to summarize this year: *Taking Gems From Fire* — a fitting description of Linear Capital's work this past year.
Linear Capital | Linear Path, Nonlinear Growth
Striving to become China's best frontier tech and innovation fund.
"Yinghua Chenrui" Zhou Zhen: Solving Biomaterial Industry Bottlenecks with Unique Modification Technology and Processing Techniques | Linear Capital Portfolio Interview Series
In late December 2023, bio-based materials high-performance modification and application innovation company **Yinghua Chenrui** announced the completion of a tens of millions of RMB angel funding round.
Linear Capital's 2023 Retrospective: Moving Forward Through Challenges
In September 2023, [when summarizing Linear Capital's ninth anniversary, we wrote this line: the goal lies far ahead, the road remains difficult, but there is light in our hearts](https://mp.weixin.qq.com/s?__biz=MzAwNTAyMDAyNQ==&mid=2652305248&idx=1&sn=eb922534db0722f5ef06117e
Bio-materials high-performance modification and application innovation company "Yinghua Chenrui" raises tens of millions of RMB in angel funding, led by Linear Capital
Output high-performance bio-based material modification capabilities.
